Compare BLIN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLIN | NDRA |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 8.2M |
| IPO Year | 2018 | 2016 |
| Metric | BLIN | NDRA |
|---|---|---|
| Price | $0.71 | $4.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 59.8K | 15.9K |
| Earning Date | 08-13-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,568,000.00 | N/A |
| Revenue This Year | $20.26 | N/A |
| Revenue Next Year | $21.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $2.96 |
| 52 Week High | $1.42 | $6.95 |
| Indicator | BLIN | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 41.75 |
| Support Level | $0.69 | $4.27 |
| Resistance Level | $1.05 | $4.90 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 18.30 | 25.23 |
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.